Abiopharma

New Form SCHEDULE 13G/A - KOHLS Corp <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000052388-26-000219 <b>Size:</b> 14 KB

New Form 424B3 - Wheeler Real Estate Investment Trust, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001527541-26-000287 <b>Size:</b> 125 KB

New Form SCHEDULE 13G/A - Dianthus Therapeutics, Inc. /DE/ <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005203 <b>Size:</b> 11 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001213900-26-089484 <b>Size:</b> 743 KB

New Form SCHEDULE 13G/A - Viridian Therapeutics, Inc.\DE <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003486 <b>Size:</b> 11 KB

New Form SCHEDULE 13G - Design Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005202 <b>Size:</b> 15 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Changes in Interest of Director - Mr. Lim Yingjie Eugene

New Form SCHEDULE 13G/A - CYBIN INC. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005201 <b>Size:</b> 11 KB

New Form SCHEDULE 13G/A - INFINITY NATURAL RESOURCES, INC. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000052388-26-000217 <b>Size:</b> 14 KB

New Form SCHEDULE 13G/A - Personalis, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003485 <b>Size:</b> 11 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: NOTIFICATION FOR DIRECTOR/CEO

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement: Half Yearly Results

New Form SCHEDULE 13G/A - ENTRAVISION COMMUNICATIONS CORP <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000052388-26-000215 <b>Size:</b> 14 KB

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): NOTIFICATION FOR SUBSTANTIAL SHAREHOLDER - U.I.P. HOLDINGS LIMITED